Eiger Biopharmaceuticals Inc (EIGR) has fallen Friday morning, with the stock falling -5.13% in pre-market trading to 1.11. EIGR's short-term technical score of 0 indicates that the stock has traded less bullishly over the last month than 100% of stocks on the market. In the Biotechnology industry, which ranks 124 out of 146 industries, EIGR ranks higher than 1% of stocks. Eiger Biopharmaceuticals Inc has fallen 71.04% over the past month, closing at $4.45 on November 11. During this period of time, the stock fell as low as $1.17 and as high as $4.69. EIGR has an average analyst recommendation of Strong Buy. The company has an average price target of $32.00.
EIGR has an Overall Score of 24. Find out what this means to you and get the rest of the rankings on EIGR!